Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00463788
Status:
COMPLETED
Last Update Posted:
2014-02-13
First Post:
2007-04-19
Brief Title:
Cetuximab and Cisplatin in the Treatment of Triple Negative Estrogen Receptor ER Negative Progesterone Receptor PgR Negative and Human Epidermal Growth Factor Receptor 2 HER2 Negative Metastatic Breast Cancer
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-19
First Submit QC Date:
April 19 2007
Study First Post Date:
2007-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-10-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-20
Last Update Post Date:
2014-02-13
Last Update Post Date Type:
ESTIMATED